Expert Interviews

The expert interviews section of Medical Economics features exclusive video interviews with physicians and other experts on important topics facing physicians, the health care system, and more.

Lisa Grabl © CHG Healthcare

Locum tenens physicians: A vital bridge for strained health systems

Austin Littrell

Lisa Grabl, group president of CHG Healthcare, explains the role of locum tenens in bridging staffing gaps.

Lisa Grabl © CHG Healthcare

Locum tenens physicians: Delivering strong outcomes

Austin Littrell

Lisa Grabl, group president of CHG Healthcare, discusses care outcomes from locum tenens physicians.

Lisa Grabl © CHG Healthcare

Locum tenens physicians: Extending careers amid workforce shortages

Austin Littrell

Lisa Grabl, group president of CHG Healthcare, talks about the role of locum tenens in the ongoing physician shortage.

Lisa Grabl © CHG Healthcare

Locum tenens physicians: A flexible path to fight burnout

Austin Littrell

Lisa Grabl, group president of CHG Healthcare, says more physicians are turning to locum tenens work as means to combat burnout.

Lisa Grabl © CHG Healthcare

Locum tenens physicians: Building trust in unfamiliar communities

Austin Littrell

Lisa Grabl, group president of CHG Healthcare, discusses the challenges locum tenens physicians face when working in Health Professional Shortage Areas.

Lisa Grabl © CHG Healthcare

Locum tenens physicians: Bridging care gaps in underserved communities

Austin Littrell

Lisa Grabl, group president of CHG Healthcare, explains the vital role locum tenens physicians play in underserved areas.

Remote monitoring technologies: What’s working, and how to pay for it

Remote monitoring technologies: What’s working, and how to pay for it

Richard Payerchin

Peterson Center on Healthcare analyzes Medicare data to make policy recommendations for remote patient monitoring.

The bad news on vaccines: Trump administration health policy is undermining efforts

The bad news on vaccines: Trump administration health policy is undermining efforts

Heather Stoltzfus, M.P.H., R.N., CIC ;Georges Benjamin, M.D., FACP;Jen Brull, M.D., FAAFP;William Schaffner, M.D.;Tina Q. Tan, M.D., FAAP, FIDSA, FDIPS;Charles Vega, MD

An expert physician panel discusses how vaccine policy has gone wrong under the Trump administration, why misinformation has flourished and what individual physicians can do to win back patient trust.

Remote patient monitoring policy: Recommendations for changing codes and payment

Remote patient monitoring policy: Recommendations for changing codes and payment

Richard Payerchin

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Remote patient monitoring policy: Goals, duration and clinical success with RPM

Remote patient monitoring policy: Goals, duration and clinical success with RPM

Richard Payerchin

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Remote patient monitoring policy: Effects on diabetes care

Remote patient monitoring policy: Effects on diabetes care

Richard Payerchin

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Remote patient monitoring policy: Clinical success, part 2 — musculoskeletal conditions

Remote patient monitoring policy: Clinical success, part 2 — musculoskeletal conditions

Richard Payerchin

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Remote patient monitoring policy: Clinical success, part 1 — hypertension

Remote patient monitoring policy: Clinical success, part 1 — hypertension

Richard Payerchin

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Remote patient monitoring policy: A surprising finding on duration of use

Remote patient monitoring policy: A surprising finding on duration of use

Richard Payerchin

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Remote patient monitoring policy: Time for a review of Medicare spending

Remote patient monitoring policy: Time for a review of Medicare spending

Richard Payerchin

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Remote patient monitoring policy: An introduction to the Peterson Center on Healthcare

Remote patient monitoring policy: An introduction to the Peterson Center on Healthcare

Richard Payerchin

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Compounded GLP-1 RA drugs: Getting to know about pharmacy compounding

Compounded GLP-1 RA drugs: Getting to know about pharmacy compounding

Richard Payerchin

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Compounded GLP-1 RA drugs: Advice to physicians and other prescribers

Compounded GLP-1 RA drugs: Advice to physicians and other prescribers

Richard Payerchin

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Compounded GLP-1 RA drugs: What about prices? Are compounded drugs cheaper or more expensive than manufacturers’ versions?

Compounded GLP-1 RA drugs: What about prices? Are compounded drugs cheaper or more expensive than manufacturers’ versions?

Richard Payerchin

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Biden prostate cancer diagnosis: A physician expert offers his first impressions

Biden prostate cancer diagnosis: A physician expert offers his first impressions

Richard Payerchin

The former president likely will have drug therapy to lower his testosterone levels, but there are other treatment options.

Compounded GLP-1 RA drugs: Can pharmacists make drugs that are essentially a copy of another drug? Part 2

Compounded GLP-1 RA drugs: Can pharmacists make drugs that are essentially a copy of another drug? Part 2

Richard Payerchin

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

The good news on vaccines: Innovation is flourishing

The good news on vaccines: Innovation is flourishing

Heather Stoltzfus, M.P.H., R.N., CIC ;Georges Benjamin, M.D., FACP;Jen Brull, M.D., FAAFP;William Schaffner, M.D.;Tina Q. Tan, M.D., FAAP, FIDSA, FDIPS;Charles Vega, MD

An expert physician panel discusses how vaccine policy has gone wrong under the Trump administration, why misinformation has flourished and what individual physicians can do to win back patient trust.

Biden prostate cancer diagnosis: The newest developments for doctors

Biden prostate cancer diagnosis: The newest developments for doctors

Richard Payerchin

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Biden prostate cancer diagnosis: The importance of primary care and cancer detection

Biden prostate cancer diagnosis: The importance of primary care and cancer detection

Richard Payerchin

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Biden prostate cancer diagnosis: Surgerical options, and discovering the disease

Biden prostate cancer diagnosis: Surgerical options, and discovering the disease

Richard Payerchin

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Biden prostate cancer diagnosis: Treatment options

Biden prostate cancer diagnosis: Treatment options

Richard Payerchin

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Biden prostate cancer diagnosis: What we know so far

Biden prostate cancer diagnosis: What we know so far

Richard Payerchin

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Compounded GLP-1 RA drugs: GLP-1 RA drugs are no longer in shortage, but compounding customized versions of them may continue, part 1

Compounded GLP-1 RA drugs: GLP-1 RA drugs are no longer in shortage, but compounding customized versions of them may continue, part 1

Richard Payerchin

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Compounded GLP-1 RA drugs: A continuing discussion about GLP-1 RA drugs, the perfect storm of demand and shortages, part 2

Compounded GLP-1 RA drugs: A continuing discussion about GLP-1 RA drugs, the perfect storm of demand and shortages, part 2

Richard Payerchin

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Compounded GLP-1 RA drugs: Are GLP-1 RA drugs the biggest phenomenon in American health care? Part 1

Compounded GLP-1 RA drugs: Are GLP-1 RA drugs the biggest phenomenon in American health care? Part 1

Richard Payerchin

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

...

3 4 5 6 7 8 9 10 11

...

Editorial Staff

Terms and Conditions

Contributor Guidelines

Do Not Sell My Personal Information

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences

All rights reserved.